Drug Topics November 16, 2023
Pearl Steinzor

VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals.

The Vaccine Adverse Event Reporting System (VAERS), comanaged by the CDC and FDA, may not be operating as intended.

A study published in The BMJ found that VAERS may not be meeting its own standards, with inefficiencies in design, transparency concerns, limited user-friendliness and responsiveness, lack of publicly available data, inadequate staffing and delayed responses, inconsistencies in acknowledging adverse events (AEs), and challenges in updating reports.1

VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals. The reporting system relies on voluntary AE reports from doctors and patients and mandatory reporting from...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Survey / Study, Trends
Vaccines And AI
'Nobody knew exactly what to do': Five years on, what scientific lessons were learned during COVID?
World Tuberculosis Day 2025: the end of TB is possible
Did people experiencing homelessness have worse in-hospital outcomes from COVID-19 than housed people?
Measles cases surpass 2024 total: 3 notes

Share This Article